WO2003048185A3 - Angiopioetin related factors - Google Patents
Angiopioetin related factors Download PDFInfo
- Publication number
- WO2003048185A3 WO2003048185A3 PCT/US2002/037660 US0237660W WO03048185A3 WO 2003048185 A3 WO2003048185 A3 WO 2003048185A3 US 0237660 W US0237660 W US 0237660W WO 03048185 A3 WO03048185 A3 WO 03048185A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wild
- domain
- amino acid
- acid sequence
- fusion proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002359464A AU2002359464A1 (en) | 2001-11-30 | 2002-11-21 | Angiopioetin related factors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33448801P | 2001-11-30 | 2001-11-30 | |
US60/334,488 | 2001-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003048185A2 WO2003048185A2 (en) | 2003-06-12 |
WO2003048185A3 true WO2003048185A3 (en) | 2004-06-24 |
Family
ID=23307442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/037660 WO2003048185A2 (en) | 2001-11-30 | 2002-11-21 | Angiopioetin related factors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002359464A1 (en) |
WO (1) | WO2003048185A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050123925A1 (en) | 2002-11-15 | 2005-06-09 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
US7081443B2 (en) | 2002-05-21 | 2006-07-25 | Korea Advanced Institutes Of Science And Technology (Kaist) | Chimeric comp-ang1 molecule |
US7371384B2 (en) | 2004-07-20 | 2008-05-13 | Genentech, Inc. | Compositions and methods of using angiopoietin-like 4 protein antibody |
US8604185B2 (en) | 2004-07-20 | 2013-12-10 | Genentech, Inc. | Inhibitors of angiopoietin-like 4 protein, combinations, and their use |
NZ552956A (en) | 2004-07-20 | 2010-03-26 | Genentech Inc | Inhibitors of angiopoietin-like 4 protein (ANGPTL4), combinations, and their use for treating cancer |
EP2457578B1 (en) * | 2004-09-28 | 2015-08-19 | Aprogen, Inc. | Chimeric molecule comprising angiopoietin-1 and a coiled-coil domain for use in treating penile erectile dysfunction |
EP1835929B8 (en) | 2005-01-06 | 2016-07-27 | Novo Nordisk A/S | Anti-kir combination treatments and methods |
US7829673B2 (en) | 2005-03-23 | 2010-11-09 | Genmab A/S | Antibodies against CD38 for treatment of multiple myeloma |
SG10201603962TA (en) | 2011-05-25 | 2016-07-28 | Innate Pharma Sa | Anti-kir antibodies for the treatment of inflammatory disorders |
WO2013154744A1 (en) * | 2012-04-13 | 2013-10-17 | Cornell University | Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction |
US9540428B2 (en) * | 2012-07-03 | 2017-01-10 | Ecole Polytechnique Federale De Lausanne (Epfl) | Extracellular matrix heparin-binding domains |
GB202108761D0 (en) * | 2021-06-18 | 2021-08-04 | Ikarovec Ltd | Ocular disorders |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6074873A (en) * | 1997-09-19 | 2000-06-13 | Genentech, Inc. | Nucleic acids encoding NL-3 |
US6265564B1 (en) * | 1996-08-02 | 2001-07-24 | Regeneron Pharmaceuticals, Inc. | Expressed ligand-vascular intercellular signalling molecule |
US6406693B1 (en) * | 1998-07-13 | 2002-06-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using antibodies to aminophospholipids |
-
2002
- 2002-11-21 AU AU2002359464A patent/AU2002359464A1/en not_active Abandoned
- 2002-11-21 WO PCT/US2002/037660 patent/WO2003048185A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265564B1 (en) * | 1996-08-02 | 2001-07-24 | Regeneron Pharmaceuticals, Inc. | Expressed ligand-vascular intercellular signalling molecule |
US20030092891A1 (en) * | 1996-08-02 | 2003-05-15 | Samuel Davis | Expressed ligand - vascular intercellular signalling molecule |
US6074873A (en) * | 1997-09-19 | 2000-06-13 | Genentech, Inc. | Nucleic acids encoding NL-3 |
US6406693B1 (en) * | 1998-07-13 | 2002-06-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using antibodies to aminophospholipids |
Also Published As
Publication number | Publication date |
---|---|
AU2002359464A1 (en) | 2003-06-17 |
AU2002359464A8 (en) | 2003-06-17 |
WO2003048185A2 (en) | 2003-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003048185A3 (en) | Angiopioetin related factors | |
WO2002059306A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002040683A3 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
WO2002077190A8 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002072765A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2003006485A3 (en) | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | |
WO2003033675A3 (en) | Identification of binding partners for specific proteins | |
WO2002046406A3 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
WO2001081412A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
WO2002068648A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof | |
WO2003074675A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002074976A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002079494A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002024910A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
WO2002057310A3 (en) | Human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
WO2002081654A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002072831A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002061088A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002079386A3 (en) | Isolated human ras-like proteins, nucleic and acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002079407A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002022678A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
WO2002062849A3 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding them, and uses thereof | |
WO2002074973A8 (en) | Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof | |
WO2002068468A3 (en) | Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof | |
WO2002079227A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |